Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 4
2017 3
2018 2
2019 3
2020 6
2021 10
2022 6
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Anti-PD-1: When to Stop Treatment.
Jansen Y, van der Veldt AAM, Awada G, Neyns B. Jansen Y, et al. Among authors: awada g. Curr Oncol Rep. 2022 Jul;24(7):905-915. doi: 10.1007/s11912-022-01264-6. Epub 2022 Mar 26. Curr Oncol Rep. 2022. PMID: 35347590 Review.
Rare side-effects of checkpoint inhibitors.
Kourie HR, Awada G, Awada AH. Kourie HR, et al. Among authors: awada g. Curr Opin Oncol. 2016 Jul;28(4):295-305. doi: 10.1097/CCO.0000000000000294. Curr Opin Oncol. 2016. PMID: 27153354 Review.
Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial.
Schwarze JK, Tijtgat J, Awada G, Cras L, Vasaturo A, Bagnall C, Forsyth R, Dufait I, Tuyaerts S, Van Riet I, Neyns B. Schwarze JK, et al. Among authors: awada g. J Immunother Cancer. 2022 Sep;10(9):e005141. doi: 10.1136/jitc-2022-005141. J Immunother Cancer. 2022. PMID: 36113895 Free PMC article. Clinical Trial.
36 results